Apyx Medical (APYX) revenue breakdown
By segment, Surgical Aesthetics is the largest at 86% of fiscal 2025 revenue, growing 33% a year over 9 years.
By region, UNITED STATES is the largest at 73% of fiscal 2025 revenue; Non-US grew fastest, 34% a year over 8 years.
Revenue by segment
Fiscal years, as Apyx Medical reports them in its 10-K filings; fiscal 2025 total $53M.
| Segments | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Surgical Aesthetics | $3M | $8M | $13M | $23M | $22M | $43M | $37M | $43M | $39M | $45M | 86% |
| OEM | $5M | $3M | $4M | $6M | $5M | $6M | $8M | $9M | $9M | $8M | 14% |
Revenue by region
Fiscal years, as Apyx Medical reports them in its 10-K filings; fiscal 2025 total $53M.
| Regions | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $9M | $13M | $20M | $19M | $33M | $31M | $38M | $34M | $39M | 73% |
| Non-US | $1M | $4M | $9M | $9M | $16M | $13M | $14M | $14M | $14M | 27% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for APYX.
Open APYX in InvestinglyQuestions
Where does Apyx Medical make its money?
In fiscal 2025, by segment: Surgical Aesthetics $45M, OEM $8M.
From Apyx Medical's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.